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Abstract
Background: High doses of ionizing radiation result in biological damage; however, the precise relationships between long-
term health effects, including cancer, and low-dose exposures remain poorly understood and are currently extrapolated
using high-dose exposure data. Identifying the signaling pathways and individual proteins affected at the post-translational
level by radiation should shed valuable insight into the molecular mechanisms that regulate dose-dependent responses to
radiation.
Principal Findings: We have identified 7117 unique phosphopeptides (2566 phosphoproteins) from control and irradiated
(2 and 50 cGy) primary human skin fibroblasts 1 h post-exposure. Semi-quantitative label-free analyses were performed to
identify phosphopeptides that are apparently altered by radiation exposure. This screen identified phosphorylation sites on
proteins with known roles in radiation responses including TP53BP1 as well as previously unidentified radiation-responsive
proteins such as the candidate tumor suppressor SASH1. Bioinformatic analyses suggest that low and high doses of
radiation affect both overlapping and unique biological processes and suggest a role for MAP kinase and protein kinase A
(PKA) signaling in the radiation response as well as differential regulation of p53 networks at low and high doses of
radiation.
Conclusions: Our results represent the most comprehensive analysis of the phosphoproteomes of human primary
fibroblasts exposed to multiple doses of ionizing radiation published to date and provide a basis for the systems-level
identification of biological processes, molecular pathways and individual proteins regulated in a dose dependent manner by
ionizing radiation. Further study of these modified proteins and affected networks should help to define the molecular
mechanisms that regulate biological responses to radiation at different radiation doses and elucidate the impact of low-
dose radiation exposure on human health.
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Introduction
Humans are continuously exposed to low doses of ionizing
radiation from both environmental (radon and cosmic rays) and
manmade (nuclear power plants and medical procedures) sources,
and the health impacts from these exposures are still not well
understood[1]. Exposure to these low doses of ionizing radiation
could account for some of the frequent cancers that develop as well as
other adverse health effects. Numerous studies have documented the
effects of high-dose radiation exposure on human health and
identified many of the underlying molecular mechanisms that lead
to mutations, cancer development and death [2]. A central challenge
of radiation research is to understand whether the biological
pathways linked to health effects induced by high radiation doses
behave in a nonlinear or linear manner at low doses. Implicit in this
challenge is the need to understand the underlying mechanisms that
govern the overall response of normal tissues exposed to low-dose
radiation. In many cases, the effects of low-dose exposure are
extrapolated from higher dose studies to assess potential health risks
because of the lack of available data on low-dose effects[3]. Emerging
evidence, however, suggests that the biological responses to low- and
high-dose exposures may be significantly different, as evidenced by
altered gene and protein expression profiles[4,5], altered protein post-
translational modifications (PTMs)[6], and findings that cancer risks
from low-dose exposure may be overestimated[7]. These investiga-
tions show that extrapolation from high-dose experiments may not
PLoS ONE | www.plosone.org 1 November 2010 | Volume 5 | Issue 11 | e14152adequately reflect the low-dose response and point to the need for
new studies to explore this issue.
Biological systems are more complex than defined by the
genome due in large part to the presence of PTMs that regulate
protein activity. Known PTMs on proteins such as histone
H2A.X, CHK2, ATM, and p53 undergo very robust changes in
response to high doses of radiation compared to changes in protein
levels. Phosphorylation, one of the most important and best
characterized PTMs[8], is essential in signal transduction, gene
regulation, and metabolic control in cells, especially in response to
intracellular and extracellular changes and stimuli. Therefore,
identification of phosphoproteins, specific phosphorylation sites
that regulate protein function, and upstream signaling kinases will
provide valuable insight into the molecular mechanisms that
regulate the cellular responses to ionizing radiation.
While traditional methods (e.g., immunohistochemistry) typically
allow characterization of one phosphoprotein (often only one specific
phosphorylation site) at a time, recent advancements in LC-MS
technology now enable the broad proteome-wide study of phosphor-
ylation (phosphoproteomics)[9,10,11,12,13] and enable identification
of thousands of phosphorylations sites (and often multiple sites in an
individual protein) in a particular proteome. Applying a data analysis
pipeline specifically designed to facilitate phosphoproteomics analy-
ses[14], we analyzed alterations in the phosphoproteome present in
skin fibroblasts treated with 2 and 50 cGy of ionizing radiation 1 h
post-irradiation. A total of 7117 phosphopeptides from control and
irradiated primary human skin fibroblasts were identified, which
represents a greater than 10-fold improvement on our previously
reported phosphoproteomic study [6].
Results and Discussion
To identify molecular targets of low-dose radiation exposure,
primary normal human dermal fibroblasts were exposed to 0, 2, or
50 cGy of ionizing radiation and processed 1 h after exposure.
Following trypsinization, phosphopeptides were enriched using
IMAC and subjected to LC-MS/MS. A total of 7117 total unique
phosphopeptides with a False Discovery Rate (FDR) of
#0.5%[14] were identified and distributed across each condition
as shown in Figure 1A, and the complete list of phosphopeptides
identified from four technical replicates is shown in Table S1.
Statistical methods used in comparative quantitation of peptides
detected in label-free MS experiments can be used to facilitate
comparison across different conditions and are typically based on
comparison of the peak intensities of the MS parent ion or the
number of MS/MS spectral counts from each peptide[15]. While
these methods are semi-quantitative in nature, they are frequently
used for comparative analyses of peptide and protein abundance
differences. In the case of whole proteins, multiple peptides from
the parent protein can be used to gain confidence in the
quantitation. With phosphorylation site analysis, there is usually
only one available peptide so that there is the potential for a larger
margin for error in the statistical analysis. With data from four
technical replicates available, we expect that semi-quantitative
evaluation can reveal apparent phosphorylation changes caused by
the low-dose radiation, which as a proof-of-principle, will provide
the rationale for future, more comprehensive and accurate
quantitative experiments by employing several biological repli-
cates, static isotopic labeling such as iTRAQ and validation
experiments with antibodies, and site-directed mutagenesis.
With this caveat in mind we employed the two semi-quantitative
methods based on spectral counting and peak intensities to identify
phosphopeptides that are apparently altered in the 2- and 50-cGy
samples relative to the sham irradiated control (Figure 1B).
Application of the spectral count based G-test revealed 145 2-cGy
and 88 50-cGy phosphopeptides with abundance significantly
different from control at 95% confidence. Application of the T-test
Figure 1. Summary of phosphoproteomic data. A. Venn diagram showing the distribution of phosphopeptides in sham, 2 cGy and 50 cGy
treated cells. B. Quantitation of significantly altered peptides using peak intensities and spectral counting methods. C. Validation of YAP1 S127
phosphorylation by Western blotting. YAP1 S127 phosphorylation increases over time at both the lower and higher dose while CHK2 T68
phosphorylation peaks at earlier timepoints. The same samples probed with YAP1 and CHK2 antibodies showed no changes in YAP1 or CHK2 total
protein at these timepoints.
doi:10.1371/journal.pone.0014152.g001
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cGy phosphopeptides, respectively, showing 2.5-fold and higher
changes in abundance at 95% confidence. Given the different
nature of these tests, these two methods provide largely non-
overlapping phosphopeptides. Combining the data from the two
methods identified 286 2-cGy and 245 50-cGy phosphopeptides
corresponding to 233 2-cGy and 187 50-cGy affected proteins.
The top phosphopeptides showing the greatest fold change for
peak intensities and spectral counts are shown in Tables 1 and 2,
and the complete list of significantly changed phosphopeptides can
be found in Tables S2 and S3.
A notable example showing overlap between the spectral count
and peak intensity data is the SSRP1 phosphopeptide containing
phospho-serine 444 (S444) for which we identified an 8- and 6.5-
fold increase in the phosphorylation by spectral counting and a
6.5- and a 4.9-fold increase in peak intensities at 2 and 50 cGy,
respectively (Tables 1 and 2). SSRP1 along with Spt16 comprises
the FACT complex, which acts as a histone chaperone to
temporarily displace histones during transcription[16,17]. It has
also been recently shown that FACT catalyzes the exchange of
H2AX at sites of DNA damage[18] and regulates homologous
recombination during DNA repair[19] suggesting that the
radiation-induced phosphorylation could play a role in regulating
this process.
To validate our proteomics data, Western blots were performed
using available phosphorylation-specific antibodies. While most of
the identified phosphorylation sites have not been extensively
studied, and therefore, few phosphorylation specific antibodies are
available, Yes Associated Protein 1 (YAP1) S127 is known to be
phosphorylated on the site that serves to regulate its apoptotic and
transcriptional activity [20]. Using the phosphorylation-specific
antibody, we confirmed by Western blot that the S127 site
undergoes increased phosphorylation after radiation treatment in
agreement with the mass spectrometry data showing a 2.6-fold
increase following exposure to radiation (Figure 1C). In the case
of YAP1, phosphorylation increases over time (up to 4 h)
especially at low doses. In contrast, Chk2 T68, which was not
detected in the current screen but is also phosphorylated at low
Table 1. Top phosphopeptides identified by peak intensities.
Gene Peptide
T-test: 2
cGy:C
T-test: 50
cGy:C 2 cGy/C 50 cGy/C Site PotentialKinase
SASH1 R.TCS*FGGFDLTNR.S 0.0034 ND 24.7 ND S407 AKT
NEXN K.AEIKEMLAS*DDEEDVSSKVEK.A 0.0007 0.0024 13.7 21.5 S80 CK II
C11orf58 R.S*ASPDDDLGSSNWEAADLGNEER.K 0.0012 0.0036 21.4 14.6 S15 None
BYSL R.MPQDGS*DDEDEEWPTLEK.A 0.0108 0.2031 21.1 22.6 S98 CK II
MAP1B R.DVMS*DETNNEETESPSQEFVNITK.Y 0.0450 0.0140 6.8 20.2 S1144 CK II
PXN K.TGSSS*PPGGPPKPGSQLDSMLGSLQSDLNK.L 0.0016 0.0144 14.4 14.8 S288 Erk1
GFPT1 R.VDS*TTCLFPVEEK.A 0.0239 0.0064 14.2 3.5 S243 AMPK
AHSG K.CDSSPDS*AEDVRK.V 0.0428 0.0115 12.0 4.1 S138 DNA PK
PLEC1 R.TS*SEDNLYLAVLR.A 0.0092 0.0001 12.0 10.4 S20 PKA
CDC42EP1 K.NAIS*LPQLNQAAYDSLVVGK.L 0.0006 0.0019 8.4 11.3 S121 None
ATP2B1 R.IEDS*EPHIPLIDDTDAEDDAPTK.R ,.0000 ,.0000 8.6 10.8 S1193 CK II
CFL1 K.LGGS*AVISLEGKPL.- 0.0006 0.0072 10.8 10.3 S155 None
LEO1 K.KYVIS*DEEEEDDD.- 0.0211 0.0024 6.2 9.6 S658 CK II
TBC1D4 R.SLTSS*LENIFSR.G 0.0026 0.0016 9.0 7.3 S570 PKC
SR-A1 R.FDIYDPFHPTDEAYS*PPPAPEQK.Y 0.0015 0.0027 6.3 8.8 S239 Erk1
ZC3H13 R.NTEESS*SPVRK.E 0.0379 0.2075 8.8 7.2 S111 None
MAP4 K.TEVALAKDMES*PTKLDVTLAK.D 0.0004 0.0012 8.6 6.0 S280 Cdk5
SEPT2 K.IYHLPDAES*DEDEDFKEQTR.L 0.0032 ,.0000 7.9 8.5 S218 CK II
ARHGEF6 K.S*TAALEEDAQILK.V 0.0199 0.0177 6.3 8.3 S649 PKC
ATP2B1 R.IEDS*EPHIPLIDDTDAEDDAPTKR.N 0.0043 0.0151 8.2 6.6 S1193 None
MATR3 R.RDS*FDDRGPSLNPVLDYDHGSR.S 0.0001 0.0013 6.1 8.2 S188 CLK2
HDAC1 R.MLPHAPGVQMQAIPEDAIPEES*GDEDEDDPDKR.I 0.0368 0.0177 5.4 8.2 S393 CK II
PLEC1 R.T*SSEDNLYLAVLR.A 0.0021 ,.0000 8.1 7.0 T19 PKA
ITGA4 R.RDS*WSYINSK.S 0.0334 0.0068 7.8 4.4 S1027 PKA
CEP170 R.QGS*FTIEKPSPNIPIELIPHINK.Q 0.0105 0.0014 2.8 7.7 S838 CAMK2G
USP8 R.SYS*SPDITQAIQEEEK.R 0.1368 0.0092 7.8 7.2 S718 AKT
EIF5B K.WDGS*EEDEDNSK.K 0.0245 0.0009 7.7 4.9 S164 CK II
TP53BP1 K.MVIQGPSS*PQGEAMVTDVLEDQKEGR.S 0.0176 0.0436 6.2 7.2 S1114 Erk1
IFI16 K.VSEEQTQPPS*PAGAGMSTAMGR.S 0.0179 0.0252 0.15 0.24 S153 ERK1
WRNIP1 K.RPAAAAAAGSAS*PR.S 0.1212 0.020 0.36 0.096 S151 None
The T-test was used to identify significantly affected phosphopeptides based on relative peak intensities. The complete list can be found in supplementary Table 2.
doi:10.1371/journal.pone.0014152.t001
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PLoS ONE | www.plosone.org 4 November 2010 | Volume 5 | Issue 11 | e14152doses, peaks at early time points indicating that different
phosphorylation sites have different temporal and dose kinetics.
Protein kinases affected by radiation
To determine if specific kinases were activated by exposure of
cells to 2 or 50 cGy ionizing radiation, we performed a kinase
motif analysis using the Scansite website (http://scansite.mit.
edu[21]). Shown in Tables 1 and 2 are the top potential kinases
for each identified phosphopeptide. Casein kinase II (CK II)
consensus sites were the most prominent and several studies have
linked CK II as a key regulator of ionizing radiation responses
[22,23]. Several sites predicted to be phosphorylated by DNA
damage regulated kinases, ATM, and DNA protein kinase (DNA
PK) were also identified, and most of the CK II sites could also be
phosphorylated by DNA PK due to the close similarities of these
motifs. Other kinases for which consensus motifs were identified
include AKT, ERK, PKC, and PKA.
Biological pathways affected by radiation exposure
Comparison of the 2-cGy and 50-cGy datasets shows that there
are 121 overlapping phosphopeptides, 166 unique 2-cGy phos-
phopeptides, and 123 unique 50-cGy phosphopeptides. Rolled up
to the protein level, there were 118 overlapping proteins, 113
unique 2-cGy proteins and 64 unique 50-cGy proteins. To identify
specific biological pathways affected by radiation, bioinformatics
analyses were performed using the MetaCore software from
GeneGo, Inc. (St Joseph, MI). Among the top radiation-affected
pathways (both 2- and 50-cGy datasets) identified by MetaCore
was the PKA signaling pathway (Figure 2). Specific components
of this pathway included the PKA regulatory subunit (PRKAR2A);
Figure 2. Implication of PKA signaling in radiation response. A. Top molecular pathways affected by radiation identified by MetaCore. B.
Western Blotting with PKA motif antibody demonstrates that PKA substrates are differentially phosphorylated following radiation exposure in
different subcellular compartments. NHDF cells were exposed to 0 or 50 cGY of ionizing radiation and subcellular fractionation was performed 1 h
post-radiation.
doi:10.1371/journal.pone.0014152.g002
Low Dose Radiation Signaling
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which regulate PKA activity by anchoring this kinase to specific
intracellular domains[24]; and 3-phosphoinositide dependent
protein kinase-1 (PDK1), which phosphorylates and activates the
catalytic domain of PKA[25] (Table 3). All of these proteins were
significantly affected at the phosphorylation level in the 2- and 50-
cGY treated cells with the exception of AKAP11, which was not
significantly altered at 2 cGy.
PKA phosphorylates a general consensus motif of KRXXpS/
pT or RRXpS/pT[26,27] although there are many cases in the
literature showing that PKA phosphorylates other sites as well.
Using an antibody recognizing the RRXpS motif (Phospho-PKA
Substrate #100G7E, Cell Signaling Technology), we were able to
demonstrate that a number of PKA substrates are affected by
radiation exposure (Figure 2). These changes were not readily
evident when whole cell lysates were analyzed (data not shown),
but when Western blots were performed on subcellular fractions, a
number of PKA substrates were observed to be altered in
radiation-exposed cells compared to sham-irradiated cells. We
observed both increased and decreased phosphorylation of these
substrates indicating that the radiation treatment does not lead to a
general increase in PKA activity, but that the effects are targeted
to specific PKA substrates in different subcellular compartments.
Given the role of AKAPs in regulating PKA localization and
activity, it is plausible to speculate that the altered PKA
phosphorylation patterns could be attributed to the differential
AKAP phosphorylation observed.
To identify PKA substrates within our dataset, we searched the
significantly altered phosphopeptides for PKA consensus phos-
phorylation motifs using Scansite and identified 49 phosphopep-
tides that contain a potential PKA phosphorylation motif. The 2-
cGy dataset contained 36 PKA phosphopeptides while the 50-cGy
dataset contained 42 PKA phosphopeptides. In agreement with
our Western blot data we observed both increased (42 phospho-
peptides) and decreased (7 phosphopeptides) PKA-dependent
phosphorylation. The complete list of PKA substrates is presented
in Table S4.
To determine if other protein kinase signaling pathways were
affected by radiation, we analyzed our datasets for the presence of
protein kinase pathway members that are phosphorylated or
dephosphorylated after radiation treatments, which could account
for their altered activity. Shown in Table 3 is a partial list of
kinases and kinase regulatory proteins affected by radiation
treatment. Of interest is the finding that several kinase pathways
with known links to radiation effects are directly affected at the
phosphorylation level by radiation. Proteins showing altered
phosphorylation include several components of the MAP kinase
signaling pathway including MAPK1 (ERK2), MAP3K11, and
MAP4K4. ERK phosphorylation is known to increase following
exposure to low and high doses of ionizing radiation and may play
a role in regulating the adaptive response of low-dose radiation to
high challenging doses [28,29]. Activation of ERK2 signaling is
associated with dual phosphorylation of both T184 and Y186,
while here we observe only the single phosphorylation at Y186.
Also of interest is the finding that oxysterol-binding protein 1
(OSBP) is phosphorylated on several sites (S190, S193, S238 and
S240) in both the 2- and 50-cGy samples. OSBP functions as a
cholesterol sensing scaffolding protein that may regulate ERK1/2
activity by binding to and regulating the tyrosine and threonine
phosphatases that act on the T184 and Y186 sites on ERK2[30].
Recently, functional studies of OSBP S240 phosphorylation by
protein kinase D (PKD) demonstrated the involvement of this site
in regulating the localization of OSBP to the Golgi apparatus[31].
PKD S205 phosphorylation was also significantly increased in the
50-cGy treated cells (PRKD1 gene product; Table 3). This
phosphorylation site on PKD regulates apoptosis signal-regulating
kinase 1 (ASK1) association and c-Jun N-terminal kinase (JNK)
signaling cascades under conditions of oxidative stress[32].
Other important signaling proteins of note include Epidermal
Growth Factor Receptor (T369), c-Abl (S569), and Protein Kinase
C Delta binding protein (PRKCDBP; S165; S166), which
undergoes a large change in phosphorylation at 50 cGy only.
EGFR regulates radiation responses through activation of AKT
and phosphatidylinositide 3-kinase (PI3K). Recent evidence
Table 3. Kinases and regulators affected by radiation.
Gene Peptide T-test: 2 cGy T-test: 50 cGy Change2 cGy Change 50 cGy
ABL1 K.GQGESDPLDHEPAVS*PLLPR.K 0.0113 0.0008 2.6 2.9
AKAP11 R.SVS*PTFLNPSDENLK.T 0.1771 0.0046 2.7 2.0
MAPK1 R.VADPDHDHTGFLTEY*VATR.W 0.0009 0.0031 2.8 2.5
PDPK1 R.ANS*FVGTAQYVSPELLTEK.S 0.0043 0.0132 3.5 3.2
PRKAB2 R.DLSSS*PPGPYGQEMYAFR.S 0.0009 0.0106 3.6 2.7
G-Test: 2 cGy G-Test: 50 cGy Spectra: 0:2 cGy Spectra: 0:50 cGy
PRKAR2A VADAKGDS*ES*EEDEDLEVPVPSR 16.76 11.45 38:11 38:11
AKAP12 VLSKPPEGVVSEVEMLSS*QER 0.52 7.35 0:1 0:7
AKAP2 TNGHS*PSQPR 6.73 4.94 11: 2 11: 2
MAP3K11 NVFEVGPGDS*PTFPR 5.13 0.23 5:0 5:3
MAP4K4 RDS*PLQGSGQQNSQAGQR 0.78 4.37 8:5 8:1
PRKCDBP APEPLGPADQSELGPEQLEAEVGES*S*DEEPVESR 0 37.86 0:0 0:35
PRKD1 RLS*NVSLTGVSTIR 1.28 4.13 5:2 5:0
EGFR ELVEPLT*PSGEAPNQALLR 5.13 4.13 5:0 5:0
Shown is a partial list of the kinases and regulatory proteins affected by 2 and 50 cGY of radiation. The top group of peptides were identified using the peak intensity
methods and T-test for quantification. The fold change for each peptide relative to control is shown. The bottom group of peptides were identified based on spectral
counts using the G-test to assess significance. In both cases, those peptides showing significant change from control values are shown in bold.
doi:10.1371/journal.pone.0014152.t003
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mediated through its translocation to the nucleus[33], where it acts
to repair DNA damage[33]. T669 is a major ERK-dependent
phosphorylation site on EGFR following EGF stimulation and is
involved in receptor internalization[34], suggesting a link between
the observed radiation-induced phosphorylation and EGFR
involvement in DNA damage repair.
DNA damage repair proteins
A number of proteins associated with radiation responses and
DNA damage repair were identified in our screen. Prominent
among these is p53-binding protein 1 (53BP1), which translocates
to intranuclear foci containing gamma-H2AX following treat-
ments with radiation doses as low as 1 cGy[35], where it plays an
important role in DNA damage recognition[36]. We identified two
2-cGy sites (S1114 and S1462) and three 50-cGy sites (S831,
S1114, and S1317) that exhibited an increase in phosphorylation
at these radiation doses (Tables S2 and S3). Interestingly, the
majority of these phosphorylation sites are present within the
minimal domain required for foci localization[37], suggesting that
the phosphorylation could play a role in regulating 53BP1
localization.
Biological pathways affected by low doses of radiation
A critical question in low-dose radiation research is to determine
if a linear no threshold (LNT) model is valid for assessing human
health risks of low-dose radiation exposure. A number of studies
have called into question the validity of the LNT model by
showing that many radiation effects involving DNA damage
repair, transcriptional activation, and apoptosis as well as animal
epidemiological data show both qualitative and quantitative
differences at low versus high doses of radiation[38].
Many of the phosphopeptides we identified were present in both
the 2- and 50-cGy datasets, suggesting that many of the signaling
mechanisms are conserved at low- and high-dose exposures. The
KEGG pathways that were most affected by radiation exposure,
shown in Table 4, are comparable at the two doses in terms of the
numbers of proteins involved in each pathway. The top signaling
pathways affected by radiation include insulin signaling through
PRKA and MAPK signaling, both mentioned above. Interestingly,
only the spliceosome pathway showed a dose effect, involving
many more members at the high dose than the low dose. SNW1,
also known as SKI interacting protein, is required for SKI
oncoprotein transforming activity and has been shown to release
the growth suppressive activity of the retinoblastoma tumor
suppressor[39,40].
We also observed a large number of 2-cGy phosphopeptides
that were not significantly affected in 50-cGy affected cells,
suggesting that there may be signaling mechanisms that are unique
to low-dose exposures. Using statistical enrichment analysis, we
identified those biological processes that were affected by either 2-
or 50-cGy exposures (Figure 3). Multiple proteins involved in
embryonic development, nuclear transport, cell morphogenesis,
and chemotaxis were phosphorylated by 2-cGy exposure, while
proteins involved in negative regulation of translation were
significantly phosphorylated by 50-cGy exposure. Most notably
responsive to the 2-cGy dose group was the chemotaxis process,
which contains RALBP1 and TSC2. RALBP1 aids in the
clearance of glutathione-conjugated electrophilic compounds, such
as biproducts of oxidative stress, and loss of this protein is
associated with sensitivity to radiation[41]. The TSC-mTOR
pathway (also shown in Table 4) is a key regulator of innate
immune homeostasis, whose dysregulation has been shown to be a
contributor to tumor development[42,43].
A closer look at the p53 regulatory network for the KEGG
cancer pathway is shown in Figure 4. Blue dots indicate a
phosphorylation change with a low dose of radiation and red dots
indicate a phosphorylation change with a high dose of radiation.
Several proteins have red/blue hatched dots, which indicate that
their phosphorylation state was affected by both low and high
doses of radiation. Interestingly, at low doses of radiation there are
two proteins, c-Jun and SUMO-1, that are uniquely affected by
low dose and act as repressors of p53. The c-Jun protein has a
double phosphorylation on T239 and S243 found only in the 2-
cGy sample. The S243 phosphorylation is known to regulate c-Jun
protein stability [44] and possibly affect the c-Jun role in
proapoptotic signaling following radiation exposure[45]. At higher
doses of radiation, there is phosphorylation of PML, which is a
known p53 activator[46]. IFI16, which plays a role in p53-
dependent DNA repair and transcriptional pathways and also
regulates the production and secretion of multiple chemokines and
cytokines driving the initial steps in the inflammatory process, is
dephosphorylated following 2- and 50-cGy exposures[47].
Through this network, it is possible that p53 is differentially
regulated leading to dose-dependent changes in p53 transcrip-
tional activity [48] and different p53 dependent phenotypic effects,
Table 4. KEGG pathways affected by radiation.
KEGG pathway 2 cGy 50 cGy
Count Proteins Count Proteins
Insulin signaling pathway 8 MAPK1, PDPK1, IRS2, EIF4EBP1, PRKAR2A,
TSC1, PRKAB2, TSC2
6 PDPK1, IRS2, PRKAR2A, EIF4EBP1, TSC1,
PRKAB2
Pathways in cancer 7 EGFR, MAPK1, CCDC6, HDAC1, RALBP1,
JUN, ABL1
5 EGFR, HDAC1, PML, LOC652671, ABL1
MAPK signaling pathway 6 EGFR, MAPK1, JUN, RRAS, STMN1, MAP3K11 6 EGFR, MAP4K4, NF1, RRAS, NFATC4, STMN1
mTOR signaling pathway 6 EIF4B, MAPK1, PDPK1, EIF4EBP1, TSC1, TSC2 4 EIF4B, PDPK1, EIF4EBP1, TSC1
Tight junction 6 EPB41L2, RAB3B, TJP1, MAGI1, RRAS, TJAP1 4 EPB41L2, MAGI1, RRAS, TJP2
Adherens junction 6 EGFR, MAPK1, TJP1, BAIAP2, LMO7, VCL 3 EGFR, LMO7, CTNND1
Endocytosis 5 EGFR, DAB2, RABEP1, SH3KBP1, IQSEC1 4 EGFR, USP8, SH3KBP1, IQSEC1
Spliceosome 1 SF3B2 6 SFRS4, SFRS9, SNW1, SFRS1, PRPF38B, SF3B2
The DAVID web portal was used to calculate statistical enrichment of KEGG pathways.
doi:10.1371/journal.pone.0014152.t004
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significance (p=0.05) identified using the DAVID web portal.
doi:10.1371/journal.pone.0014152.g003
Figure 4. p53 regulatory network affected by radiation exposure. The blue dots adjacent to specific proteins indicate phosphorylation
change by low dose, red dots indicate phosphorylation change by high dose, and red/blue hatched dots indicate change by both dose groups. Green
edges (lines) between proteins indicate activation of the protein at the head of the arrow, and red edges indicate inactivation.
doi:10.1371/journal.pone.0014152.g004
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responses at higher doses[50].
Perhaps the strongest evidence for unique low-dose-dependent
signaling is the finding that some phosphopeptides undergo very
large changes only in the 2-cGy treated cells making it unlikely
that these changes are due to random chance. A good example of
this is SASH1, a candidate tumor suppressor[51,52,53], for which
we observed an ,25-fold increase in phosphorylation at S407 only
at the 2-cGy dose (Table 1). In addition to S407, we also
observed significant changes in SASH1 phosphorylation at S837
and S839 (Table S2) at both 2- and 50-cGy doses indicating that
this protein has multiple dose-dependent phosphorylation sites.
Other phosphoproteins uniquely affected by 2-cGy treatment and
showing many-fold changes in phosphorylation include c-jun as
mentioned above; Nipbl, which is mutated in Cornelia de Lange
syndrome and reportedly affects DNA damage sensitivity in these
patients[54]; and Vinexin (SORBS3), which interacts with and is
phosphorylated by ERK1/2, mediating the effects of EGF
signaling on anchorage-dependent growth[55]. Further analysis
of these proteins and their PTMs should help to provide
mechanistic insight into the physiological implications of low dose
radiation exposure.
Materials and Methods
Reagents
All reagents were obtained from Sigma-Aldrich (St. Louis, MO)
unless otherwise noted below. Antibodies used in Western blots
(YAP1, YAP1 pS127, Chk2, Chk2 pT68, and Phospho-PKA
Substrate #100G7E) were obtained from Cell Signaling Tech-
nology (Beverly, MA).
Cell Culture
Primary normal human dermal fibroblast (NHDF) cells were
obtained from Lonza (Rockland, ME) and cultured in Fibroblast
Growth Media-2 (FGM-2; Lonza). Cells were grown in 150-mm
plates to confluence for 2 days to induce growth arrest and
irradiated with 0, 2-, or 50-cGy low-LET radiation generated
using a Pantek XRAD 320 irradiator (GE Inspection Technolo-
gies, General Electric Co., Hurth, Germany). Cell fractionation
experiments were performed using the Subcellular Protein
Fractionation Kit (Thermo Fisher Scientific, Rockford, IL).
Protein Digestion and Cleanup
1 h post irradiation, cell lysates were prepared by direct
addition of freshly made 8 M urea in 50 mM ammonium
bicarbonate (pH 8.0) containing a 1X concentration of phospha-
tase inhibitor cocktail (Thermo Fisher Scientific, Rockford, IL)
followed by scraping cells and shearing DNA using an 18 gauge
needle. After incubation on ice for 30 minutes, insoluble matter
was removed by centrifugation at 16,0006g for 20 minutes.
Protein Digestion and Methyl Esterification
Samples were diluted 2-fold with 50 mM NH4HCO3 (pH 7.8)
and digested with sequencing grade modified trypsin (Promega,
Madison, WI) at a trypsin to protein ratio of 1:100 (w/w) at room
temperature for 6 h with constant shaking at 300 rpm in
Thermomixer R (Eppendorf, Hauppauge, NY), and then were
further diluted 4-fold, followed by an additional 16 h at room
temperature after treatment with a second aliquot of trypsin at the
same trypsin-to-protein ratio. While trypsin is only partially active
in 4 M urea, performing the first digestion at this concentration
enables digestion of the denatured proteins into larger fragments
that are completely digested using trypsin in 1 M urea. We find
this two-step digestion provides superior digestion of difficult to
digest proteins. To prevent potential carbamylation of proteins in
urea [56], we used freshly made urea buffer and performed
digestions at room temperature.
Samples were acidified with Trifluoroacetic acid (TFA) (0.5%
final concentration TFA) to interrupt digestion. The tryptic digests
were ultracentrifuged (166,0006g for 30 min at 4uC) to remove
nucleic acids prior to SPE desalting[57]. Each desalted sample
(500 mg) was completely dried using a Speed-Vac SC 250 Express
(Thermo Savant, Holbrook, NY). For peptide methyl esterifica-
tion, 40 ml of thionyl chloride was added drop-wise to 1 ml
anhydrous methanol with constant stirring. After ,5 min, the
mixture was cooled and added at ,100 mL/100 mg ratio to the
dried peptide, sonicated for 10 min at room temperature, and
vortexed for another 5 min at room temperature. After incubation
at room temperature for 1 h, the methyl esterified peptides were
completely dried again using a Speed-Vac concentrator and kept
at -80uC until time for further use.
Phosphopeptide Enrichment and Capillary HPLC-MS/MS
Analysis
Methyl esterified peptides were subjected to Fe
3+ immobilized
metal affinity chromatography (IMAC) to enrich phosphopeptides.
A custom-packed IMAC Macrotrap cartridge (3 mm i.d. 68m m
length) (Michrom BioResources, Inc., Auburn, CA) was employed
for phosphopeptide enrichment. Briefly, using a syringe pump, the
IMAC cartridge was activated with 500 mL of 100 mM FeCl3 at
25 mL/min, the excess metal ions were removed with 250 mLo f
0.01% acetic acid (HOAc) at 50 mL/min, and the column was
equilibrated with 500.0 mL of wash buffer (1:1:l of 0.01% HOAc/
Acetonitrile/Methanol) at 50 mL/min. Methyl esterified peptides
from each sample condition were resuspended in 250 mL of wash
buffer, and the pH was adjusted using 10% ammonium hydroxide
to ,3.5. The sample was then loaded onto the IMAC cartridge at
4 mL/min and washed with 100 mL of wash buffer at 25 mL/min
and with 600 mL of wash buffer at 50 mL/min. The IMAC
column was then re-equilibrated with 500 mL of 0.01% HOAc at
50 mL/min before the phosphopeptide elution using 250 mLo f
250 mM Na2HPO4 pH,8.0 at 10 mL/min. The eluate was
immediately acidified with TFA to pH ,3.5-4.
After IMAC enrichment, aliquots (1/12 of the IMAC eluate)
were analyzed on a ThermoElectron LTQ-Orbitrap (Waltham,
MA) coupled to an automated dual-column phosphoproteome
nano-HPLC platform assembled in-house[58]. The LC gradient
(A=100 mM HOAc in H2O, B=70% acetonitrile/100 mM
HOAc in H2O) was 0-70% B for ,180 min. Full-scan mass
spectra were acquired over an m/z range of 300 to 1575 and
either MS/MS for the top 10 abundant species or multi-stage
activation (MSA) for the top 6 abundant species for a given MS
scan was used for peptide fragmentation. Survey spectra were
acquired with a resolution of 60,000 in the Orbitrap while
acquiring tandem mass spectra in the LTQ part of the instrument.
For MSA, during fragmentation, the neutral loss species resulting
from phosphate loss and a combination of water and phosphate
loss at 97.97, 115.97, 48.99, 57.99, 32.66, or 38.66 m/z below the
precursor ion were activated in turn for 30 ms each[59]. For each
sample, 4 technical replicates of MS analyses were performed.
Database search and peptide identification
Phosphopeptides were identified from MS/MS spectra using
SEQUEST (Sequest Cluster version 27 revision 12 from Bioworks
3.2, ThermoElectron Corp., Waltham, MA) by searching against
the Human IPI database (version 3.20, 61,225 protein sequences,
www.ebi.ac.uk/IPI, European Bioinformatics Institute, Cam-
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termini (allowing #2 missed cleavages) (amino- and carboxy-
termini were considered tryptic termini). (2) Dynamic modifica-
tions: an addition of 79.9663 Da to serine, threonine, and tyrosine
residues (phosphorylation). (3) Static modifications: an addition of
14.0157 Da to aspartic acid, glutamic acid, and the carboxy-
terminus (methyl esterification). (4) Precursor ion mass tolerance:
60.05 Da. (5) Fragment ion mass tolerance: 60.5 Da (m/z). (6)
Maximum number of the same amino acid that can be
dynamically modified in a phosphopeptide: 3. The false discovery
rate (FDR) of phosphopeptide identification was controlled at #
0.5% using our in-house developed software[14]. This program
also measured the probability of correct phosphorylation site
localization in each identified peptide by calculating the AScore
for each phosphorylation site using Gygi’s approach[60], which is
shown in Table S1.
Statistical analysis for phosphopeptide changes with
radiation exposure
We use both spectral count and peak area methods to evaluate
the changes of phosphopeptides. The total spectral counts for each
identified phosphopeptide in each radiation condition and their
ratios were used to semi-quantitatively estimate their abundance in
each condition[61]. The G-test was used to assess significance of
spectral count data at the 95% confidence level[62]. We also used
the peak areas of phosphopeptides identified in each of four MS
technical replicates to evaluate the phosphopeptide abundance
changes. Cross-correlation analyses of each replicate (supplemen-
tary Figure S1) were performed and generated scores ranging
from 0.79 to 0.93, where 100% correlation between replicates
would yield a score of 1. Briefly, the peak area for each
phosphopeptide was extracted from the MS data applying the
MASIC program developed in-house[63] and used to assess
phosphopeptide abundance. To obtain significant changed
phosphopeptides under control and each radiation condition, the
T-test was performed for the phosphopeptides identified from each
condition across four MS technical replicates, and p,0.05 was
used to filter the non-significantly changed proteins. All signifi-
cantly changed phosphopeptides were combined for the final list
using either spectral count or peak area methods.
Bioinformatics Analyses
Phosphorylated protein lists were used to determine biological
pathways affected by radiation exposure. The MetaCore software
(GeneGo Inc, St Joseph, MI) was used to identify common
molecular pathways at both doses and to create regulatory
networks for selected pathways. The DAVID web portal[64,65]
was used to calculate statistical enrichment of KEGG pathways
and Gene Ontology biological processes for each dose group
separately. Process groups were considered significant with at least
5 protein members and p,0.05. Kinase motif analysis was
performed using the Scansite web tool (http://scansite.mit.
edu[21]).
Supporting Information
Figure S1. Cross correlation analysis of technical replicates.
Phosphopeptide correlation plots (Log 2 Peak intensities) within 4
LC-MS/MS technical replicates for each condition are shown.
The red line corresponds to Y=X. The data points along the X or
Y axis are unique to one technical replicate. The correlation values
are shown diagonally across the correlation plot for the 2 replicates
compared.
Found at: doi:10.1371/journal.pone.0014152.s001 (2.85 MB EPS)
Table S1. Shown is the complete list of identified phosphopep-
tides.
Found at: doi:10.1371/journal.pone.0014152.s002 (6.92 MB
XLS)
Table S2. Significantly altered phosphopeptides based on peak
intensities.
Found at: doi:10.1371/journal.pone.0014152.s003 (0.08 MB
XLS)
Table S3. Significantly alterered phosphopeptides based on
spectral counts. The G-test was used to identify significantly
affected phosphopeptides based on the number of observed
spectra. NS = not significant.
Found at: doi:10.1371/journal.pone.0014152.s004 (0.06 MB
XLS)
Table S4. Potential PKA substrates identified using SCAN-
SITE.
Found at: doi:10.1371/journal.pone.0014152.s005 (0.21 MB
XLS)
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